Peptidream Incis A Biopharmaceutical Company Based In Kawasakijapanfounded In July 2006The Company Specializes In The Discovery And Development Of Macrocyclic Peptides Through Its Proprietary Peptide Discovery Platform Systempdps This Technology Allows Peptidream To Create Diverse Non Standard Peptide Librarieswhich Are Essential For Developing Peptide Based Therapeutics And Diagnostics Peptidream Offers A Variety Of Peptide Based Products And Servicesincluding Therapeutic And Diagnostic Applicationsits Product Pipeline Features Items Like 18F Flortaucipir18F Pd L1And Various Inhibitorswhich Are Utilized In Peptide Drug Conjugates And Multi Functional Peptide Conjugatesthe Company Also Markets Radiopharmaceutical And Radiodiagnostic Products Through Its Subsidiaries And Has Formed Joint Ventures To Enhance Its Capabilities In The Pharmaceutical Sector Peptidream Has Established Partnerships With Several Leading Pharmaceutical Companiesincluding Amgenastrazenecaand Novartisand Has Successfully Transferred Its Pdps Platform For Broader Applicationsthe Company Has Been Profitable Since Its Second Year And Continues To Focus On Collaborative Partnerships To Drive Growth
